Senate Finance Committee investigating J&J
Executive Summary
The Senate Finance Committee is seeking information from Johnson & Johnson on medical education activities the company funded for its heartburn drug Propulsid (cisapride). A July 5 letter to the company from committee Chairman Charles Grassley (R-Iowa) and Ranking Member Max Baucus (D-Mont.) cites a June New York Times article discussing promotion of Propulsid's use in children before the company ceased marketing the product in 2000. The committee asks J&J to identify specific dollar amounts for educational grants and employees responsible for those grants between 1993 and 2000...
You may also be interested in...
Sales/Marketing Sway In Educational Grants Under Scrutiny By Senate
The Senate Finance Committee is asking drug companies to explain the role sales and marketing executives play in educational grants bestowed to professional societies
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.